Related references
Note: Only part of the references are listed.Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and Postinfection Immunity Limited Evidence, Many Remaining Questions
Robert D. Kirkcaldy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
Javier A. Jaimes et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Susceptibility of SARS-CoV-2 to UV Irradiation
Christiane Silke Heilingloh et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2020)
Viral dynamics in mild and severe cases of COVID-19
Yang Liu et al.
LANCET INFECTIOUS DISEASES (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
Jingxian Zhao et al.
SCIENCE IMMUNOLOGY (2017)
A structural analysis of M protein in coronavirus assembly and morphology
Benjamin W. Neuman et al.
JOURNAL OF STRUCTURAL BIOLOGY (2011)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
T-cell epitopes in Severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS
YD Wang et al.
JOURNAL OF VIROLOGY (2004)
Share Paper
